Company intelligence / Profile preview
ABON Biopharm
Hangzhou, Zhejiang, Chinaabon.com.cn ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
ABON Biopharm is a leading Chinese developer and manufacturer of lateral flow and in vitro diagnostic (IVD) products with global regulatory certifications. The company has a pipeline that includes an early-stage therapeutic mRNA vaccine targeting EGFR mutations in lung cancer as well as a broad portfolio of commercialized rapid diagnostic tests across several therapeutic areas.
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodyPolyclonal antibodyGene recombinant antigenSynthetic antigen techniquesmRNA vaccineTherapeutic vaccine
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on ABON Biopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ABON Biopharm.